RxDoctor Payments Data

Andrew Sun, MD

Urology · Arlington, TXNPI 1033553409

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (55.7%), grants and food and beverage — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 66.0% of it on its own, with 39 other manufacturers making up the rest. Among urology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$280,175in general payments, 2019–2025

Across 703 payments — averaging $398.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$185K
  • Endo Pharmaceuticals Inc.$64K
  • Endo USA, Inc.$21K
  • Coloplast$4K
  • Neotract Inc.$1K
  • Antares Pharma, Inc.$624
  • plus $4K from 34 others
$10,600in research payments, 2019–2025

Across 2 payments — averaging $5300.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Endo USA, Inc.$11K

What the payments were for

  • Consulting fees$24,4279%
  • Speaking & faculty fees$155,97856%
  • Grants$50,00018%
  • Travel & lodging$22,5548%
  • Food & beverage$26,90210%
  • Education$3140%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$280,175 in reported general payments places this provider in the 95th percentile of 878 urology providers in Texas.

See all urology providers in Texas

Medicare billing

Part B allowed, 2024
$371,688
Medicare patients
494
Services billed
4,926

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Testosterone Cypionate151$7,203
Testosterone11$1,280
Finasteride49$800
Tamsulosin Hcl76$550
Alfuzosin Hcl ErAlfuzosin Hcl29$333
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim52$214
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen60$196
Anastrozole29$139
Meloxicam56$66
Tramadol Hcl16$18

Paid to pharmacies, not to this prescriber.

Other urology in Arlington

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →